However, higher IL-33 levels were observed in a subgroup of patients with low adiponectin levels who also exhibited fewer features of metabolic syndrome, leading the authors to suggest that a combined analysis of IL-33 and adiponectin may be a useful predictor of inflammatory status during the preliminary onset of metabolic syndrome. The gene discussed is IL33; the disease is metabolic syndrome.